HIV-1 diseases progression associated with loss of Th17 cells in subtype 'C' infection

Cytokine

Volumn 60, Issue 1, 2012, Pages 55-63

  Singh, Alpana ^a,b   Vajpayee, Madhu ^a   Ali, Sharique A ^b   Mojumdar, Kamalika ^a   Chauhan, Neeraj Kumar ^a   Singh, Ravinder ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b BARKATULLAH UNIVERSITY   (India)

Author keywords

HIV 1; IL 17; IL 21; Plasma viral load; Th17 cells

Indexed keywords

EFAVIRENZ; GAG PROTEIN; INTERLEUKIN 17; INTERLEUKIN 21; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC DIARRHEA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; GASTROINTESTINAL INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH17 CELL; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MALE; TH17 CELLS; TIME FACTORS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84865421464     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.288     Document Type: Article

References (21)

1. Awasthi A., Kuchroo V.K. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009, 21:489-498.
2. Klatt N.R., Brenchley J.M. Th17 cell dynamics in HIV infection. Curr Opin HIV AIDS 2010, 5:135-140.
3. Bettelli E., Korn T., Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007, 19:652-657.
4. Ancuta P., Monteiro P., Sekaly R.P. Th17 lineage commitment and HIV-1 pathogenesis. Curr Opin HIV AIDS 2010, 5:158-165.
5. Yue F.Y., Merchant A., Kovacs C.M., Loutfy M., Persad D., Ostrowski M.A. Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection. J Virol 2008, 82:6767-6771.
6. Maek A.N.W., Buranapraditkun S., Klaewsongkram J., Ruxrungtham K. Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection. Viral Immunol 2007, 20:66-75.
7. Brenchley J.M., Paiardini M., Knox K.S., Asher A.I., Cervasi B., Asher T.E., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112:2826-2835.
8. Hou W., Kang H.S., Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 2009, 206:313-328.
9. Dandekar S., George M.D., Baumler A.J. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 2010, 5:173-178.
10. Elhed A., Unutmaz D. Th17 cells and HIV infection. Curr Opin HIV AIDS 2010, 5:146-150.
11. Hemdan N.Y., Birkenmeier G., Wichmann G., Abu El-Saad A.M., Krieger T., Conrad K., et al. Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 2010, 9:785-792.
12. Leipe J., Grunke M., Dechant C., Reindl C., Kerzendorf U., Schulze-Koops H., et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 2010, 62:2876-2885.
13. Ndhlovu L.C., Chapman J.M., Jha A.R., Snyder-Cappione J.E., Pagan M., Leal F.E., et al. Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS 2008, 22:990-992.
14. Cecchinato V., Trindade C.J., Laurence A., Heraud J.M., Brenchley J.M., Ferrari M.G., et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 2008, 1:279-288.
15. Alvarez Y., Tuen M., Nàdas A., Hioe C.E. In Vitro restoration of Th17 response during HIV infection with an antiretroviral drug and th17 differentiation cytokines. AIDS Res Hum Retrov 2011.
16. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin17 producing CD4 effector T cells developing via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
17. Salgado M., Rallón N.I., Rodés B., López M., Soriano V., Benito J.M. Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clin Immunol 2011, 139(2):110-114.
18. Yue F.Y., Lo C., Sakhdari A., Lee E.Y., Kovacs C.M., Benko E., et al. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J Immunol 2010, 185:498-506.
19. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8(9):942-949.
20. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8(9):950-957.
21. Manel N., Unutmaz D., Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008, 9(6):641-649.